Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in IntangiblesChange in InventoryGains from Investment SecuritiesNet Debt Issuances and RepaymentsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Asset Writedowns and Impairment: 2022-2023

Historic Asset Writedowns and Impairment for Mainz Biomed N.V (MYNZ) over the last 1 years, with Sep 2023 value amounting to $42,045.

  • Mainz Biomed N.V's Asset Writedowns and Impairment rose 9045.74% to $42,045 in Q3 2023 from the same period last year, while for Sep 2023 it was $94,870, marking a year-over-year change of. This contributed to the annual value of $47,449 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2023, Mainz Biomed N.V's Asset Writedowns and Impairment is $42,045, which was up 4,204,600.00% from -$1 recorded in Q2 2023.
  • In the past 5 years, Mainz Biomed N.V's Asset Writedowns and Impairment ranged from a high of $53,296 in Q1 2023 and a low of -$470 during Q3 2022.
  • Moreover, its 2-year median value for Asset Writedowns and Impairment was $21,022 (2023), whereas its average is $23,718.
  • Data for Mainz Biomed N.V's Asset Writedowns and Impairment shows a peak YoY spiked of 9,045.74% (in 2023) over the last 5 years.
  • Mainz Biomed N.V's Asset Writedowns and Impairment (Quarterly) stood at -$470 in 2022, then skyrocketed by 9,045.74% to $42,045 in 2023.
  • Its last three reported values are $42,045 in Q3 2023, -$1 for Q2 2023, and $53,296 during Q1 2023.